Changes of hepatofibrosis markers in hyperthyroidism and hypothyroidism

Objective: To study the changes of hepatofibrosis markers in hyperthyroidism and hypothyroidism. Methods: The indicators of thyroid function (TT3, TT4, FT3, FT4, sTSH, TG-Ab, TM-Ab) and hepatofibrosis markers (IV-C, PCIII, HA, LN) were assayed with RIA in 57 patients with hyperthyroidism, 43 patients with hypothyroidism, 39 euthyroid patients after hyperthyroidism treated and 50 controls. Results: The serum IV-C and PC III levels in hyperthyroid patients were significantly higher than those in controls and hypothyroid patients (P<0.01). In the euthyroid subjects after successful treatment, the IV-C and PC III levels dropped markedly (vs before treatment, P<0.01). However, there were no significant differences among the serum HA, LN levels in all the subjects tested. Conclusion: Serum levels of IV-C and PC III increased markedly during hyperthyroidism. When IV-C and PC III levels were taken for judgement of degree of hepatofibrosis, hyperthyroidism must be ruled out first. The HA and LN levels were not related to the status of thyroid function. (authors)